Home
About
About Lattice Biologics
Manufacturing
The Market
Team
Board of Directors
Management
Scientific Information
Intellectual Property
Clinical Information
Research Publications
Patients
Investors
Financials
Stock Information
Webinars
Corporate Governance
RSS Feeds
Products
Soft Tissue Allografts
Dental Allografts
Membrane and Barrier Allografts
Demineralized Bone Matrix (DBM) Allografts
Safety
Allograft Processing
Certifications
Quality Assurance
Careers
Events
News
Contact
Home
About
About Lattice Biologics
Manufacturing
The Market
Team
Board of Directors
Management
Scientific Information
Intellectual Property
Clinical Information
Research Publications
Patients
Investors
Financials
Stock Information
Webinars
Corporate Governance
RSS Feeds
Products
Soft Tissue Allografts
Dental Allografts
Membrane and Barrier Allografts
Demineralized Bone Matrix (DBM) Allografts
Safety
Allograft Processing
Certifications
Quality Assurance
Careers
Events
News
Contact
Sidebar Header Top Right
Home
Sidebar Header Top Right
24 MAR 14
0
Sidebar Header Top Right
Leave a reply →
News
LATTICE BIOLOGICS LTD. REPORTS YEAR END 2018 RESULTS
2019-01-28T07:45:50-0700
LATTICE BIOLOGICS LTD. ANNOUNCES MANAGEMENT CEASE TRADE ORDER
2018-01-30T10:02:45-0700
LATTICE BIOLOGICS LTD. ANNOUNCES CHANGE IN DIRECTOR AND CHANGE IN STATUS OF CHIEF OPERATING OFFICER
2017-12-22T10:16:07-0700
LATTICE BIOLOGICS LTD. REPORTS THIRD QUARTER 2017 HIGHLIGHTS
2017-08-29T10:31:56-0700
LATTICE BIOLOGICS LTD. COMPLETES DEBT TO EQUITY CONVERSION AND ISSUES SHARES FOR SERVICES
2017-07-17T16:32:53-0700
LATTICE BIOLOGICS LTD. ANNOUNCES CHANGE IN DIRECTOR AND CHAIRMAN OF SCIENTIFIC ADVISORY BOARD
2017-07-06T16:26:08-0700
LATTICE BIOLOGICS LTD. ANNOUNCES MOVE TO BELGRADE, MT
2017-06-26T09:20:27-0700
LATTICE BIOLOGICS LTD. ANNOUNCES CHANGE TO LOCATION OF ITS ANNUAL GENERAL AND SPECIAL MEETING
2017-06-20T11:09:33-0700
LATTICE BIOLOGICS LTD. ANNOUNCES COMPLETION OF TRANSACTION TO REDUCE ROYALTY AND DEBT OBLIGATIONS
2017-06-13T11:04:15-0700
LATTICE BIOLOGICS LTD. RECEIVES MULTI-YEAR AMERICAN ASSOCIATION OF TISSUE BANKS RE-ACCREDITATION
2017-06-01T10:59:32-0700
LATTICE BIOLOGICS LTD. APPOINTS CHIEF OPERATING OFFICER
2017-05-31T10:51:13-0700
LATTICE BIOLOGICS LTD. REPORTS SECOND QUARTER 2017 HIGHLIGHTS
2017-05-30T17:12:04-0700
LATTICE BIOLOGICS ANNOUNCES COMPLETION OF PRIVATE PLACEMENT
2017-05-15T08:44:29-0700
LATTICE BIOLOGICS ANNOUNCES AGREEMENT TO SUCCESSFULLY REDUCE ROYALTY AND DEBT OBLIGATIONS
2017-04-26T09:15:59-0700
LATTICE BIOLOGICS CLOSES FIFTH TRANCHE OF PRIVATE PLACEMENT AND EXTENDS FUNDING RAISE FOR AN ADDITIONAL 30 DAYS
2017-04-04T08:31:56-0700
SERVICE PROVIDER LOYALTY REMAINS STRONG AS LATTICE BIOLOGICS ISSUES SHARES FOR SERVICES AND ANNOUNCES PLANNED DEBT-TO-EQUITY CONVERSION
2017-03-20T08:44:25-0700
LATTICE BIOLOGICS EXTENDS PRIVATE PLACEMENT
2017-03-07T13:00:57-0700
LATTICE BIOLOGICS LTD. REPORTS FIRST QUARTER 2017 HIGHLIGHTS
2017-03-01T18:00:11-0700
LATTICE BIOLOGICS PARTICIPATES IN $300 MILLION PUBLIC-PRIVATE INITIATIVE, THE ADVANCED REGENERATIVE MANUFACTURING INSTITUTE (ARMI)
2017-02-28T18:52:12-0700
LATTICE BIOLOGICS CLOSES FOURTH TRANCHE OF PRIVATE PLACEMENT ANNOUNCED ON JANUARY 19, 2017
2017-02-28T18:00:46-0700
Photostream